tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
Advertisement

Neuphoria Therapeutics (NEUP) Income Statement

Compare
251 Followers

Neuphoria Therapeutics Income Statement

Last quarter (Q3 2024), Neuphoria Therapeutics's total revenue was $15.00M, an increase of 8582.72% from the same quarter last year. In Q3, Neuphoria Therapeutics's net income was $11.26M. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 181.36K$ 0.00$ 32.06K
Gross Profit
$ 0.00$ -9.94M$ 0.00$ -2.84M
Operating Expenses
$ 17.89M$ 14.86M$ 8.96M$ 6.23M
Depreciation and Amortization
$ 662.99K$ 763.17K$ 1.28M$ 1.68M
EBITDA
$ -17.13M$ -14.32M$ -4.51M$ -1.23M
Operating Income
$ -17.89M$ -14.68M$ -8.96M$ -6.19M
Other Income/Expenses
$ 2.31M$ -419.37K$ 2.28M$ 2.05M
Pretax Income
$ -15.58M$ -15.10M$ -6.68M$ -4.14M
Net Income
$ -15.49M$ -14.97M$ -6.53M$ -4.89M
Per Share Metrics
Basic EPS
$ -0.10$ -0.13$ -0.10$ -0.11
Diluted EPS
$ -0.10$ -0.13$ -0.10$ -0.11
Weighted Average Shares Outstanding
149.80M 112.78M 65.00M 45.41M
Weighted Average Shares Outstanding (Diluted)
149.80M 112.78M 65.00M 45.41M
Currency in USD

Neuphoria Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis